NantKwest Inc and ImmunityBio at JPMorgan Healthcare Conference Transcript
Great. Hi, I'm R.A. McDonough from JPMorgan Investment Banking. Thank you all so much for joining us this morning.
Patrick Soon-Shiong is with us, and very exciting opportunity to hear about 3 companies, actually. He's going to be presenting today, ImmunityBio, which is a very large private immunotherapy company and then NantKwest and NantHealth, which are both public, and Patrick's going to talk about the intersection of all 3 companies as well as share some very exciting clinical results that he's had amongst the companies.
So with that, I'll turn it over to Patrick.
Thanks, R.A. Every year, I confuse JPMorgan about which companies I'm going to be presenting. So this year, I think it's a year where we're trying to really consider the consolidation.
And I'll just start with NantHealth, and we won't have any slides on NantHealth. But I think what was exciting for me to hear, the virology
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
